Profile
Richard L.
Rudolph joined Cyberonics, Inc. in August 2001 as Vice President of Clinical, Regulatory and Medical Affairs and Chief Medical Officer.
He was Senior Director of Clinical Research and Development for Wyeth-Ayerst Research.
Former positions of Richard L. Rudolph
| Companies | Position | End |
|---|---|---|
| CYBERONICS, INC. | Chief Tech/Sci/R&D Officer | 2008-01-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
LivaNova USA, Inc.
 LivaNova USA, Inc. Medical SpecialtiesHealth Technology LivaNova USA, Inc. engages in the design, development, sales, and marketing of implantable medical devices. It operates through providing neuromodulation therapy, vagus nerve stimulation therapy (VNS Therapy) for the treatment of refractory epilepsy, and treatment-resistant depression (TRD). The company was founded in 1987 and is headquartered in Granbury, TX. | Health Technology |
- Stock Market
- Insiders
- Richard L. Rudolph
